Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Unlock ways to monetize hobbies for fast income. Turn your passions into cash and enjoy what you love while earning.
18,004 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Ark Invest's July activity shows notable interest in Kratos Defense. This article breaks down what the buys mean, the...
As July 18, 2026 approaches, the GENIUS Act deadline accelerates rulemaking for stablecoin issuers. Regulators from T...
The U.S. launched a new wave of strikes on Iran after an attack on a civilian ship in the Strait of Hormuz, prompting...
A coalition of states filed antitrust lawsuits to block Paramount Global's planned purchase of Warner Bros. Discovery...
SoftBank CEO Masayoshi Son says global AI demand will need roughly $5 trillion each year to scale infrastructure, arg...
House Republicans rolled out a $95 billion budget blueprint aimed at defense, farming support, and stricter voter reg...
Investors are turning their attention from faster GPUs to a broader shift in AI hardware. This next stage revolution ...
As natural gas swings capture traders’ attention, UNG and FCG offer competing paths: near-term futures exposure vs. e...
The United States launched strikes on Iranian targets after an attack that killed U.S. troops in Jordan, while Tehran...
Nike has fallen sharply from its peak, but a blue-chip brand can still offer compelling upside. This guide analyzes t...
Bitcoin has shed about half its value from October peaks, testing investor nerves. Retail buyers on Coinbase persist,...